Luo Y, Li Y, Su Y, Yin H, Hu N, Wang S, Lu Q
Department of Dermatology, Epigenetic Research Centre, Second Xiangya Hospital, Central South University, Changsha, China.
Br J Dermatol. 2008 Sep;159(4):827-33. doi: 10.1111/j.1365-2133.2008.08758.x. Epub 2008 Jul 17.
Impaired methylation of T-cell DNA is thought to contribute to the development of systemic lupus erythematosus. However, it is unknown whether T-cell hypomethylation is a factor in other, less severe, forms of lupus erythematosus such as subacute cutaneous lupus erythematosus (SCLE).
To investigate global DNA methylation and the expression of genes that regulate methylation in T cells of patients with SCLE.
We quantified global methylcytosine levels in CD4+ and CD8+ T cells from 12 patients with SCLE and nine healthy controls. mRNA levels of DNA methyltransferases (DNMTs), methylated CpG binding proteins (MBDs) and CD11a were measured by real-time quantitative polymerase chain reaction.
CD4+ T-cell DNA from patients with SCLE was hypomethylated relative to controls (P = 0.002). DNMT1 and DNMT3a mRNA levels were significantly lower in CD4+ T cells from SCLE patients than in controls (P = 0.027 and P = 0.004, respectively). Relative to controls, MBD1, MBD3 and MBD4 mRNA levels were significantly higher in SCLE CD4+ cells (P < 0.001, P < 0.001 and P = 0.001, respectively), whereas MECP2 and MBD4 mRNA expression were significantly increased in SCLE CD8+ T cells (P = 0.001 and P = 0.001, respectively). DNMT1 expression positively correlated with CD4+ T-cell DNA methylation within our SCLE patient cohort (r = 0.590, P = 0.044). CD11a mRNA expression was significantly increased in SCLE CD4+ T cells relative to controls (P = 0.044) and negatively correlated with DNA methylation (r = -0.669, P = 0.049).
These data suggest that aberrant regulation of DNA methylation in CD4+ T cells is associated with the development of SCLE.
T 细胞 DNA 甲基化受损被认为与系统性红斑狼疮的发病机制有关。然而,T 细胞低甲基化是否是其他不太严重的红斑狼疮形式,如亚急性皮肤型红斑狼疮(SCLE)的一个因素尚不清楚。
研究 SCLE 患者 T 细胞中的整体 DNA 甲基化及调控甲基化的基因表达。
我们对 12 例 SCLE 患者和 9 名健康对照者的 CD4⁺和 CD8⁺T 细胞中的整体甲基胞嘧啶水平进行了定量。通过实时定量聚合酶链反应测量 DNA 甲基转移酶(DNMTs)、甲基化 CpG 结合蛋白(MBDs)和 CD11a 的 mRNA 水平。
与对照组相比,SCLE 患者的 CD4⁺T 细胞 DNA 发生低甲基化(P = 0.002)。SCLE 患者 CD4⁺T 细胞中 DNMT1 和 DNMT3a 的 mRNA 水平显著低于对照组(分别为 P = 0.027 和 P = 0.004)。相对于对照组,SCLE 的 CD4⁺细胞中 MBD1、MBD3 和 MBD4 的 mRNA 水平显著升高(分别为 P < 0.001、P < 0.001 和 P = 0.001),而 MECP2 和 MBD4 的 mRNA 表达在 SCLE 的 CD8⁺T 细胞中显著增加(分别为 P = 0.001 和 P = 0.001)。在我们的 SCLE 患者队列中,DNMT1 表达与 CD4⁺T 细胞 DNA 甲基化呈正相关(r = 0.590,P = 0.044)。相对于对照组,SCLE 的 CD4⁺T 细胞中 CD11a 的 mRNA 表达显著增加(P = 0.044),且与 DNA 甲基化呈负相关(r = -0.669,P = 0.049)。
这些数据表明,CD4⁺T 细胞中 DNA 甲基化的异常调控与 SCLE 的发病机制有关。